Automated Cell Culture System 'CellXpress.ai'
Automating the culture of 3D tissue models! Enhancing the reliability and reproducibility of assays, significantly reducing human error, and improving the productivity of the cell culture process.
Organoids derived from iPS cells and tissue stem cells are expected to serve as advanced in vitro models for disease modeling and drug screening, as they mimic human tissue structure and function, thereby improving the clinical predictability of drug responses. However, challenges such as the complexity of sample preparation, reproducibility, and scalability hinder their practical application as a major screening method in drug discovery. To address this bottleneck in sample preparation, our product does not perform mechanical operations regularly; instead, AI machine learning automatically makes decisions based on monitoring results of the samples. Under a 24-hour operational environment, it appropriately conducts and manages medium exchanges and passaging, fully automating the complex workflow of the organoid culture process. As a result, we achieve significant reductions in costs and time, as well as a decrease in human error, while enhancing the productivity of the cell culture process in assays using iPS cells and organoids. *For detailed specifications, please refer to the PDF document or feel free to consult us.*
- 企業：モレキュラーデバイスジャパン 東京本社
- 価格：Other
